Mark J. Casey's most recent trade in Novavax, Inc. was a trade of 37,500 Common Stock done . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 37,500 | 101,445 (0%) | 0% | 0 | Common Stock | |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 03 Mar 2026 | 11,378 | 90,067 (0%) | 0% | 9.5 | 107,977 | Common Stock |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 03 Mar 2026 | 4,000 | 4,000 | - | - | Restricted Stock Units | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 02 Mar 2026 | 152,000 | 152,000 | - | - | Non-Statutory Stock Option NQ | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 01 Mar 2026 | 152,000 | 152,000 | - | - | Non-Statutory Stock Opotion NQ | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 01 Mar 2026 | 101,000 | 101,000 | - | - | Restricted Stock Units | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 4,000 | 65,159 (0%) | 0% | 0 | Common Stock | |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 01 Mar 2026 | 4,000 | 4,000 | - | - | Restricted Stock Units | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.14 per share. | 01 Mar 2026 | 1,214 | 63,945 (0%) | 0% | 10.1 | 12,310 | Common Stock |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 11 Dec 2025 | 41,899 | 41,899 | - | - | Restricted Stock Units | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 41,899 | 73,972 (0%) | 0% | 0 | Common Stock | |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.69 per share. | 11 Dec 2025 | 12,713 | 61,159 (0%) | 0% | 6.7 | 85,050 | Common Stock |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 03 Mar 2025 | 169,000 | 169,000 | - | - | 2025 Non-statutory Stock Option NQ | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 03 Mar 2025 | 112,500 | 112,500 | - | - | 2025 Restricted Stock Units RSU | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 4,000 | 33,187 (0%) | 0% | 0 | Common Stock | |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 01 Mar 2025 | 4,000 | 8,000 | - | - | Restricted Stock Units | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 01 Mar 2025 | 1,214 | 31,973 (0%) | 0% | 8.3 | 10,113 | Common Stock |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 11 Dec 2024 | 41,900 | 83,798 | - | - | Restricted Stock Units | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 41,900 | 41,900 (0%) | 0% | 0 | Common Stock | |
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.82 per share. | 11 Dec 2024 | 12,713 | 29,187 (0%) | 0% | 8.8 | 112,129 | Common Stock |
| Novavax Inc | Mr. Mark J. Casey | EVP, CLO & Corporate Secretary | 01 Mar 2024 | 12,000 | 12,000 | - | - | Restricted Stock Units | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 11 Dec 2023 | 144,694 | 144,694 | - | - | Stock Options (Right to buy) | ||
| Novavax Inc | Mr. Mark J. Casey | EVP, Chief Legal Officer | 11 Dec 2023 | 125,698 | 125,698 | - | - | Restricted Stock Units |